{
  "title": "Paper_266",
  "abstract": "pmc J Exp Clin Cancer Res J Exp Clin Cancer Res 618 jeccr Journal of Experimental & Clinical Cancer Research : CR 0392-9078 1756-9966 BMC PMC12487375 PMC12487375.1 12487375 12487375 41029313 10.1186/s13046-025-03524-2 3524 1 Research MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction Bocchetti Marco m.bocchetti@unilink.it 1 2 3 4 Cossu Alessia Maria 1 3 Porru Manuela 5 Ferraro Maria Grazia 6 Irace Carlo 7 Tufano Rossella 8 9 Vitale Giovanni 10 11 Misso Gabriella 3 Amodio Nicola 12 Scrima Marianna 1 Simeone Ines 13 Ceccarelli Michele 8 9 14 Chianese Ugo 3 Altucci Lucia 3 Desiderio Vincenzo 15 Regad Tarik 4 Caraglia Michele michele.caraglia@unicampania.it 1 3 Zappavigna Silvia 3 1 https://ror.org/01ymr5447 grid.428067.f 0000 0004 4674 1402 Molecular Oncology and Precision Medicine Laboratory, Biogem IRGS, 2 https://ror.org/035mh1293 grid.459694.3 0000 0004 1765 078X Department of Life Sciences, Health and Health Professions, Link Campus University, 3 https://ror.org/02kqnpp86 grid.9841.4 0000 0001 2200 8888 Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, 4 https://ror.org/04xyxjd90 grid.12361.37 0000 0001 0727 0669 John van Geest Cancer Research Centre, Nottingham Trent University, 5 https://ror.org/04j6jb515 grid.417520.5 0000 0004 1760 5276 Translational Oncology Research Unit, IRCCS - Regina Elena National Cancer Institute, 6 https://ror.org/05290cv24 grid.4691.a 0000 0001 0790 385X Department of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, 7 https://ror.org/05290cv24 grid.4691.a 0000 0001 0790 385X Department of Pharmacy, University of Naples “Federico II”, 8 https://ror.org/01ymr5447 grid.428067.f 0000 0004 4674 1402 Laboratory of Computational Biology, Biogem IRGS, 9 https://ror.org/05290cv24 grid.4691.a 0000 0001 0790 385X Department of Electrical Engineering and Information Technologies, University of Naples “Federico II”, 10 https://ror.org/033qpss18 grid.418224.9 0000 0004 1757 9530 Laboratory of Geriatric and Oncologic Neuroendocrinology Research, IRCCS, Istituto Auxologico Italiano, 11 https://ror.org/00wjc7c48 grid.4708.b 0000 0004 1757 2822 Department of Medical Biotechnology and Translational Medicine, University of Milan, 12 https://ror.org/0530bdk91 grid.411489.1 0000 0001 2168 2547 Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 13 https://ror.org/05d538656 grid.417728.f 0000 0004 1756 8807 Humanitas Research Hospital, 14 https://ror.org/02dgjyy92 grid.26790.3a 0000 0004 1936 8606 Department of Public Health Sciences, Miller School of Medicine, University of Miami, 15 https://ror.org/02kqnpp86 grid.9841.4 0000 0001 2200 8888 Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, 30 9 2025 2025 44 478191 270 23 7 2025 18 8 2025 30 09 2025 02 10 2025 02 10 2025 © The Author(s) 2025 2025 https://creativecommons.org/licenses/by/4.0/ Open Access http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/publicdomain/zero/1.0/ Background MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are key regulators of gene expression and play a crucial role in cancer progression. Recent studies have highlighted miR-423-5p as a potential modulator in hepatocellular carcinoma (HCC), especially in patients responding to sorafenib treatment. A functional interaction with the oncogenic lncRNA MALAT-1 has been hypothesized, suggesting a regulatory mechanism that may influence tumor aggressiveness. Methods To investigate this interaction, we analyzed in silico patient datasets to correlate miR-423-5p and MALAT-1 expression with overall survival (OS) and disease free survival (DFS). Stable overexpression of miR-423-5p and MALAT-1 was achieved in HCC cell lines (HepG2, Hep3B, and SNU387) using a lentiviral transduction system. Functional assays were performed to assess proliferation, migration, invasion, and clonogenic potential. The interaction between miR-423-5p and MALAT-1 was confirmed by RNA immunoprecipitation (RIP), followed by transcriptomic analysis using next-generation sequencing (NGS). Mitochondrial activity was evaluated using the Seahorse Mito Stress Test to measure oxygen consumption rate (OCR) and ATP production. In vivo experiments in orthotopic mouse models were performed to assess tumor growth. Results Patient data analysis revealed that high miR-423-5p expression correlated with a less aggressive tumor phenotype and improved survival, while MALAT-1 was associated with poorer prognosis. In vitro, miR-423-5p overexpression reduced MALAT-1 levels and significantly impaired proliferation, migration, and invasion. NGS analysis identified transcriptomic changes linked to tumor progression and metabolic shift. The Seahorse Mito Stress Test demonstrated decreased cellular respiration and ATP production upon miR-423-5p overexpression. In vivo, both tumors derived from miR-423-5p-overexpressing cells and MALAT-1 downregulation by ASO GapmeR evidenced a significantly reduced growth compared to controls. Conclusion These findings suggest, for the first time, that miR-423-5p acts as a tumor suppressor affecting mitochondrial metabolism through MALAT-1 downregulation in HCC. This regulatory axis represents a potential therapeutic target for precision medicine approaches in liver cancer. Supplementary Information The online version contains supplementary material available at 10.1186/s13046-025-03524-2. Keywords MicroRNA HCC Mitochondria Metabolism MiR-423-5p MALAT-1 pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement yes pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes issue-copyright-statement © Italian National Cancer Institute ‘Regina Elena’ 2025 Background Liver cancer, and especially hepatocellular carcinoma (HCC), is still among the most widespread and aggressive types of cancer across the world [ 1 2 3 4 5 6 7 10 11 12 13 14 15 16 17 18 19 20 21 Results miR-423-5p and MALAT-1 in HCC patients One of lncRNAs mode of action is the regulation of miRNAs expression that, in turn, can modulate lncRNAs expression through their degradation [ 22 13 1 23 1 1 1 1 http://kmplot.com/analysis 1 p p Fig. 1 miR-423-5p targets MALAT-1 through direct interaction and correlates with survival outcomes in HCC patients. A B C D \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p < 0.05$$\\end{document} p < 0.05 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.01$$\\end{document} < 0.01 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.001$$\\end{document} < 0.001 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.0001$$\\end{document} < 0.0001 Transient miR-423-5p overexpression on HCC cell lines Based on the previous results, we have investigated upon the reciprocal regulation of the expression of miR-423-5p and MALAT-1 in HCC cell lines. Firstly, we have evaluated miR-423-5p and MALAT-1 expression levels in 7 different HCC cell lines: SNU449, HepG2, SNU475, Hep3B, SKHep1, SNU387, and SNU389, using real-time PCR analysis (Fig. 2 Fig. 2 A B C D E \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p < 0.05$$\\end{document} p < 0.05 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.01$$\\end{document} < 0.01 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.001$$\\end{document} < 0.001 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.0001$$\\end{document} < 0.0001 Stable miR-423-5p or MALAT-1 transfection induce reciprocal expression regulation To explore the prolonged impact of miR-423-5p overexpression in HCC cell lines, we generated stable overexpressing clones along with matched controls using a lentiviral transduction system (Fig. 2 2 2 miR-423-5p overexpression inhibited HCC cancer cell growth, while MALAT-1 overexpression had no effect We and others have suggested that miR-423-5p acts as a tumor suppressor in different types of cancers [ 13 24 25 3 3 3 Fig. 3 miR-423-5p overexpression reduces proliferation in HCC cell lines ( A C D E F H \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p < 0.05$$\\end{document} p < 0.05 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.01$$\\end{document} < 0.01 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.001$$\\end{document} < 0.001 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.0001$$\\end{document} < 0.0001 miR-423-5p mediated MALAT-1 downregulation inhibited HCC cells migration, invasion and clonogenicity potential Given the established link between elevated MALAT-1 expression and metastasis, we investigated the potential impact of miR-423-5p-induced MALAT-1 down-regulation on the migratory and invasive properties of HepG2, Hep3B, and SNU387 HCC cell lines. We performed migration assessment experiments using uncoated Cultrex BME plates and wound healing assays. The results, as shown in Fig. 4 4 4 4 Fig. 4 A B C \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p < 0.05$$\\end{document} p < 0.05 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.01$$\\end{document} < 0.01 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.001$$\\end{document} < 0.001 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.0001$$\\end{document} < 0.0001 MALAT-1 mediated miR-423-5p downregulation increased HCC cells migration, invasion and clonogenicity potential After the evaluation of miR-423-5p influence on HCC cell lines functional phenotype, we assessed the effects of MALAT-1 overexpression as well, in order to clarify the role of the latter in our specific HCC models. Using similar approaches we studied MALAT-1 upregulation effects on proliferation, migration, invasion and clonogenic potential on Hep3B and SNU387 clone 2 and clone 1, respectively. The DNA dye CyQuant NF fluorescence was measured at different time points (Cell attachment, 24 h, 48 h, 72 h) to measure the DNA amount reflecting the proliferation. MALAT-1 overexpressing clones’ proliferation was compared with the relative empty backbone control and shown in Fig. 3 4 4 Whole transcriptome analysis of MALAT-1 and miR-423-5p transfected HCC cells The expression profiles of SNU-387 cell lines transfected with miR-423-5p ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n = 2$$\\end{document} n = 2 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n = 2$$\\end{document} n = 2 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n = 2$$\\end{document} n = 2 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.05$$\\end{document} < 0.05 5 26 29 5 Fig. 5 The circos plots show the selected biological processes (BPs) related to A B C D p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.05$$\\end{document} < 0.05 Mitochondrial involvement The morphological and pathway modifications observed so far with both live cell imaging and whole transcriptome, respectively, led us to hypothesize a metabolic shift involving mitochondria in the miR-423-5p/MALAT-1 transduced cells. In order to study mitochondria number and shape changes, we generated a cell model with easily detectable mitochondria. This was achieved by the use of the MTS-mCherry-GFP1-10-Hyg-N1 plasmid, that was transfected in the already modified clones. After the G418 selection, pure SNU387 miR-423-5p+ and MALAT-1+ clones expressing red fluorescent mitochondria were obtained and screened with fluorescence Leica DM 6000. The panel presented in Fig. 6 6 6 Fig. 6 A B C \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p < 0.05$$\\end{document} p < 0.05 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.01$$\\end{document} < 0.01 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.001$$\\end{document} < 0.001 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.0001$$\\end{document} < 0.0001 miR-423-5p induces tumor inhibition in HCC mouse orthotopic model We started by investigating the tumorigenic potential of our HCC models. Therefore, we planned a preliminary in vivo experiment in order to set up the experimental conditions for in vivo tumorigenesis of SNU387 cell line. Initially, 1 and 5 million of miR-423-5p+ SNU387 and control cells, respectively, were orthotopically injected in three different animals per group, but unfortunately, the tumor did not growth at any cell density. Therefore, we focused on the Hep3B cells for in vivo orthotopic models (Fig. 7 7 7 Fig. 7 Figure 7. A B p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p<0.05$$\\end{document} p < 0.05 C \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p < 0.05$$\\end{document} p < 0.05 MALAT-1 knockdown confirms the lncRNA role in HCC progression in vivo miR-423-5p is involved in several intracellular modulations and is able to interfere with oncogenic processes in HCC. In particular, the miR-423-5p and MALAT-1 inverse correlation was also studied in vivo to strengthen the translational value of miR-423-5p administration and consequent MALAT-1 down regulation. To achieve MALAT-1 knockdown in vivo we used a specific short DNA antisense oligonucleotide structure with RNA-like segments (GapmeR) capable of knocking down MALAT-1 in a very similar way as miR-423-5p does. The results we obtained were encouraging since downregulating MALAT-1 had a significant impact on orthotropic HCC in vivo growth as shown in Fig. 8 Fig. 8 Figure 8 A B p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p < 0.05$$\\end{document} p < 0.05 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$< 0.01$$\\end{document} < 0.01 Methods Cell lines and growth conditions We obtained HepG2 and SNU387 HCC cell lines from the American Type Culture Collection (ATCC, Manassas, VA, USA). The Hep3B cell line was obtained from DSZM (Leibniz Institute, Berlin, Germany). These cell lines were cultivated in specific media: Eagle’s Minimum Essential Medium for HepG2 and Hep3B (BE12-6621, Lonza, Basel, Switzerland), and RPMI 1640 Medium for SNU387 (12-167Q, Lonza, Basel, Switzerland). To the media, we added 10% (v/v) fetal calf serum and 1 (w/v) L-glutamine (Lonza). The cells were incubated at 37 °C in an environment with 5% (v/v) CO2 and 100% (v/v) humidity. For the generation and culture of stable transfected cell lines expressing Mimic hsa-miR-423-5p, we employed the same culture media with the addition of 1.5 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ Transient transfection of HCC cells with miRNA 423-5p mimic and inhibitor To clarify the specific role of miRNA 423-5p, HCC cells at 80% of confluence were transfected with miRNA 423-5p mimic and its inhibitor. The day before transfection, cells were trypsinized and seeded in an appropriate medium without antibiotics in 12-well plates. MiRIDIAN miR-423-5p mimic, miRIDIAN miR-423-5p hairpin inhibitor, and their controls with unrelated sequences (Dharmacon, Lafayette, CO) were transfected at 50 nmol/l. Transfections were performed by using Lipofectamine 2000 (Invitrogen, Carlsbad, CA), as described by the manufacturer. After 6 hours, the transfection mix was replaced with complete medium. The analyses were performed 72 hours after transfection. Generation of mimic miR-423-5p HCC cell lines using lentiviral transduction system HCC cell lines HepG2, Hep3B and SNU387 were seeded in a 96 multiwell plate and the following day infected with empty vector (MISSION® pLKO.1-puro Empty Vector Control Plasmid DNA; Sigma-Aldrich) or miRIDIAN microRNA hsa-miR-423-5p shMIMIC lentiviral particles (Lentiviral Human TurboGFP shMIMIC; Thermo Scientific) at a multiplicity of infection (MOI) between 2.5 and 20. At 48 h post-infection, GFP fluorescent cells were detected by fluorescent microscopy and Puromycin (Invitrogen) was added to the medium (1.5 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ Bacteria transformation and plasmids amplification The pMD2.G, VSVG (Envelope), psPAX2 (Packaging), pLKO.1-puro Empty plasmids were amplified individually using XL1-Blue super-competent bacteria. First, the cells were thawed on ice for 5 minutes and mixed before transferring 50 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ Lentiviral particles production Target sequence plasmid, together with appropriate packaging plasmid and envelope plasmid, were transfected in HEK293T (Passage 3 maximum) using lipofectamine 2000. After 24 hours from transfection, HEK293T media containing Lentiviral Particles Fraction 1 was collected, filtered with a 0.22 μM syringe filter and split evenly in 1 mL cryovials for storage at −80°C. Fresh media was added to cells. After 48 hours from transfection, HEK293T media containing Lentiviral Particles Fraction 2 was collected, filtered with a 0.22 μM syringe filter, and split evenly into 1 mL cryovials for storage at −80°C. 1 mL of LVPs was able to transduce efficiently 80% of Wild Type cells (measured by GFP fluorescence) seeded in 6 multiwell plate. Generation of MALAT-1 HCC cell lines using a lentiviral transduction system HCC cell lines Hep3B and SNU387 were seeded in 6 multiwell plates and treated with 1 mL MALAT-1 lentiviral particles after 24 hours (HEK293T cell product, LVP titer not assessed). At 48 h post-infection, GFP fluorescent cells were detected by fluorescent microscopy and Puromycin (Invitrogen) was added to the medium (1.5 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ RNA immunoprecipitation The RNA immunoprecipitation (RIP) assay was performed using extract obtained from SNU387 clones with Magna RIP RNA-binding protein immunoprecipitation kit (MilliporeSigma) according to manufacturer protocol. Briefly, the cells were scraper detached and lysed, the magnetic beads were prepared using AGO2 RIP antibody (MilliporeSigma) and a negative control IgG antibody. Immunoprecipitation was conducted overnight at 4 °C, then RNA purified with phenol-chloroform-isoamyl alcohol. FOS primers were used to check AGO2 enrichment and successful specific immunoprecipitation by qPCR while target RNAs related cDNA and expression analysis by qPCR was performed according to the methods described below. CyQuant proliferation assay Cells were detached from respective plates and seeded in a 96-well plate at a density of 1500 per well in sextuplicate for the CyQUANT NF Cell Proliferation Assay ( C35006 Proliferation assay – live-time imaging with IncuCyte Cells were detached from respective plates and seeded in a 96-well plate at a density of 2500 and 5000 per well in sextuplicate for each cell concentration. Plates were then stored into IncuCyte Live-Time microscope incubator (37°C, 5% CO2) for a maximum of 120 hours. Capture protocol was set for 3 different captures per well, once every 30 minutes. The confluence percentage was recorded and plotted by IncuCyte software considering all the captures for each time point. Cell migration and invasion assays For wound healing assay (Scratch assay), HCC cells were cultured to 80% confluence and serum-starved for 24 h in 24 multiwell plate, then vertical scratches were drawn through the confluent monolayer of cells using a 10- \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ Colony formation assay HCC cell lines were seeded in 6 MW at low density (2.5 × 10 5 RNA extraction Total RNA was extracted using the QIAGEN miRNeasy mini kit (QIAGEN, Cat-74104) or NORGEN Total RNA Purification Kit (Cat. 17200, 37500, 17250) following the manufacturer’s instructions. Briefly, pellet cells were lysed directly adding 250 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ miRNA reverse transcription for miRNA expression analysis For miRNA expression detection, cDNA was synthesized using stem-loop reverse transcription primers using the TaqManTM microRNA reverse transcription kit (Applied Biosystems, Paisley, UK) according to the manufacturer’s instructions. Each reaction contained 5 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ mRNA reverse transcription for gene expression analysis For first-strand cDNA synthesis from RNA was prepared following the manufacturer’s instructions described below. Into a 0.5ml Eppendorf tube, 2 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ TaqMan quantitative real-time PCR miRNA qRT-PCR was performed using Taqman® miRNA Assay RT-PCR Probes and TaqMan® Universal Mastermix PCR (containing AmpliTaq Gold® DNA polymerase, dNTP mixture and optimal salt conditions, Invitrogen) on Rotor-Gene PCR cycler (Qiagen) in accordance with the manufacturer’s instructions. Each reaction master mix contained 250 nM TaqMan probe, 1 X Taqman Universal PCR MasterMix II (Invitrogen) and nuclease-free H2O to a total volume of 18,67 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ Quantitative qRT-PCR for mRNA expression qRT-PCR was set up into PCR tubes using Sybr Green SuperMix on Rotor-Gene PCR cycler (Qiagen) following manufacturer’s instructions described here per sample: 6.75 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} μ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\Delta }\\Delta$$\\end{document} Δ Δ Fluorescent mitochondria cell lines generation HCC cell lines were transfected with MTS-mCherry-GFP1-10-Hyg-N1 (Addgene plasmid # 91957) using Lipofectamine 2000 according to the manufacturer protocol. Pure population was then selected using G418 antibiotic (Sigma-Aldrich). Mitochondria were visible (Red) in vital cells using fluorescent microscopy (LEICA DM 6000 B 100x and 60x Oil), and the number and shape were recorded and compared between the cell lines. Transcriptome analysis RNA was extracted from HCC cell clones using Total RNA Purification Kit (Norgen Biotek Corp) according to the manufacturer protocol. Each cell clone was cultured in three separate flasks to achieve biological triplicates. RNA quantification and quality assessment were performed using NanoDrop 1000 Spectrophotometer (Thermo Fisher Scientific), Qubit RNA HS Assay Kit (Thermo Fisher Scientific) and Bioanalyzer Total RNA Pico Chip (Agilent). SuperScript VILO cDNA Synthesis Kit (Thermo Fisher Scientific) was used to obtain cDNA according to manufacturer protocol. IonChef (Thermo Fisher Scientific), related Ion AmpliSeq Kit for Chef DL8 (Thermo Fisher Scientific) and Trascriptomic panel (Thermo Fisher Scientific) were used to obtain sequencing libraries and sequencing chip template. The NGS runs were performed on IonS5 (Thermo Fisher Scientific) on Ion 540 Chip (Thermo Fisher Scientific). In vivo experiment All animal procedures were in compliance with the national and international directives (D.L. March 4, 2014, no. 26; directive 2010/63/EU of the European Parliament and European Council; Guide for the Care and Use of Laboratory Animals, U.S. National Research Council, 2011;Animal Research guidelines Reporting of In Vivo Experiments (ARRIVE) guidelines) and approved by the Italian Ministry of Health (authorization n.346/2020-PR, released on April 2020). Mice were maintained in a barrier facility on high-efficiency particulate air HEPA-filtered racks and received food and water ad libitum. NOD SCID (6 weeks old) male immunodeficient mice (Charles River Laboratories, Calco, Italy) were orthotopically injected in the liver with 1 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\times$$\\end{document} × 6 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\times$$\\end{document} × 6 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P < 0.05$$\\end{document} P < 0.05 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P < 0.05$$\\end{document} P < 0.05 Statistical and bioinformatic analysis All data are presented as the mean ± SEM for at least three independent experiments. For each experiment, the statistical tests are indicated in the results section. The student’s t-test was conducted using Prism 8 (Graphpad Software, La Jolla, CA, USA) to compare the means. Significant (‘*’/ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p= < 0.05$$\\end{document} p = < 0.05 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p= < 0.01$$\\end{document} p = < 0.01 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p= < 0.001$$\\end{document} p = < 0.001 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p= < 0.0001$$\\end{document} p = < 0.0001 p \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$<0.05$$\\end{document} < 0.05 http://kmplot.com/analysis p p Discussion Several studies reported a role for both miR-423-5p and MALAT-1 in the regulation of crucial tumor processes including proliferation, migration and cell metabolism. In detail, miR-423-5p was described in different cancer contexts as a potentially oncosuppressor microRNA, able to inhibit tumor growth and invasion. In ovarian cancer, miR-423-5p overexpression caused a significant reduction in the functional capabilities of tumor cells, impairing proliferation, invasion and colony formation [ 24 12 13 25 30 31 18 32 33 18 20 Conclusion In conclusion we showed the tumor suppressive role of miR-423-5p in HCC, and started to understand its complex mechanisms both describing its inverse correlation and interaction with the detrimental long non-coding RNA MALAT-1 and its role in the modulation of mitochondrial function. We employed several in vitro functional studies and also in vivo approaches to confirm our findings. This will be an interesting starting point to disclose the prognostic, diagnostic and even the possible therapeutic role of this interesting microRNA since our group is actively working on an innovative delivery method, capable of preserving the microRNA stability in the bloodstream and ensure the delivery to the tumor. Supplementary Information  Supplementary Material 1. Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Marco Bocchetti and Alessia Maria Cossu contributed equally to this work. Authors' contributions Conceptualization, M.B., M.C.,S.Z.; writing-original draft preparation, M.B., A.M.C.; Molecular and cellular biology experiments, M.B., A.M.C., M.G.F., U.C.; In Vivo experiments, M.P.; statistical analysis and bioinformatics, M.B., R.T., I.S., M.Ce.; Supervision, M.B., G.V., C.I., G.M., N.A., M.S., M.Ce., L.A., V.D., T.R., M.C., S.Z.; Funding acquisition, M.C., S.Z. All authors have read and agreed to the published version of the manuscript. Funding This work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC), Investigator Grant IG 2017, IG20711 to Prof. Michele Caraglia. Ministry of Economic Development (MiSE) for the Epi-Met project “Epi-MET-Funzionalizzazione delle aberrazioni (epi)genomiche nei tumori metastatici”, Grant number: F/310034/01-03/X56; University of Campania “L.Vanvitelli”. N.A. was supported by a grant from the Italian Association for Cancer Research (AIRC IG24449). M.Ce. was supported by EU funding within the NextGeneration EU: MUR PNRR National Center for Gene Therapy and Drugs based on RNA Technology [CN_00000041]. EU funding within the Next Generation EU, Mission 4 Component 1, CUP E53D23004630001. Data availability No datasets were generated or analysed during the current study. Declarations Ethics approval and consent to participate Animal procedures were in compliance with the national and international directives (D.L. 4 March 2014, no. 26; directive 2010/63/EU of the European Parliament and of the council; Guide for the Care and Use of Laboratory Animals, United States National Research Council, 2011) and approved by the Italian Ministry of Health (authorization n. 346/2020-PR, released on 29-04-2020). Mice were maintained in a barrier facility on high-efficiency particulate air HEPA-filtered racks and received food and water ad libitum. Consent for publication Not applicable. Competing interests The authors declare no competing interests. References 1. Singal AG Kanwal F Llovet JM Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy Nat Rev Clin Oncol. 2023 20 12 864 884 10.1038/s41571-023-00825-3 37884736 Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol. 2023;20(12):864–84. 10.1038/s41571-023-00825-3. 37884736 10.1038/s41571-023-00825-3 2. Zhang Y Lei J Ma H Zuo S Impact of Type of Lenvatinib Resistance on Prognosis and Second-Line Regimen in Patients with Virus-Associated HCC J Hepatocellular Carcinoma. 2024 11 1507 1517 10.2147/JHC.S476439 39135736 PMC11318596 Zhang Y, Lei J, Ma H, Zuo S. Impact of Type of Lenvatinib Resistance on Prognosis and Second-Line Regimen in Patients with Virus-Associated HCC. J Hepatocellular Carcinoma. 2024;11:1507–17. 10.2147/JHC.S476439. 39135736 10.2147/JHC.S476439 PMC11318596 3. Ermi AG Sarkar D Resistance to Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma (HCC): Clinical Implications and Potential Strategies to Overcome the Resistance Cancers. 2024 16 23 3944 10.3390/cancers16233944 39682130 PMC11640171 Ermi AG, Sarkar D. Resistance to Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma (HCC): Clinical Implications and Potential Strategies to Overcome the Resistance. Cancers. 2024;16(23):3944. 10.3390/cancers16233944. 39682130 10.3390/cancers16233944 PMC11640171 4. Llovet JM Kelley RK Villanueva A Singal AG Pikarsky E Roayaie S Hepatocellular carcinoma. Nat Rev Dis Primers. 2021 7 1 6 10.1038/s41572-020-00240-3 33479224 Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma Nat Rev Dis Primers. 2021;7(1):6. 10.1038/s41572-020-00240-3. 33479224 10.1038/s41572-020-00240-3 5. Bruix J Chan SL Galle PR Rimassa L Sangro B Systemic treatment of hepatocellular carcinoma: An EASL position paper J Hepatol. 2021 75 4 960 974 10.1016/j.jhep.2021.07.004 34256065 Bruix J, Chan SL, Galle PR, Rimassa L, Sangro B. Systemic treatment of hepatocellular carcinoma: An EASL position paper. J Hepatol. 2021;75(4):960–74. 10.1016/j.jhep.2021.07.004. 34256065 10.1016/j.jhep.2021.07.004 6. Villanueva A Hepatocellular carcinoma N Engl J Med. 2019 380 15 1450 1462 10.1056/NEJMra1713263 30970190 Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450–62. 10.1056/NEJMra1713263. 30970190 10.1056/NEJMra1713263 7. Cai Y, Chen J, Zhang M, Zhang Y, Wang X, et al. LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2/ 10.1186/s13046-022-02544-6 PMC9724427 36471363 8. Slack FJ Chinnaiyan AM The Role of Non-coding RNAs in Oncology Cell. 2019 179 5 1033 1055 10.1016/j.cell.2019.10.017 31730848 PMC7347159 Slack FJ, Chinnaiyan AM. The Role of Non-coding RNAs in Oncology. Cell. 2019;179(5):1033–55. 10.1016/j.cell.2019.10.017. 31730848 10.1016/j.cell.2019.10.017 PMC7347159 9. Anastasiadou E Jacob LS Slack FJ Non-coding RNA networks in cancer Nat Rev Cancer. 2018 18 1 5 18 10.1038/nrc.2017.99 29170536 PMC6337726 Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5–18. 10.1038/nrc.2017.99. 29170536 10.1038/nrc.2017.99 PMC6337726 10. Bergamini C Leoni I Rizzardi N Melli M Galvani G Coada CA MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma J Exp Clin Cancer Res. 2023 42 1 145 10.1186/s13046-023-02718-w 37301960 PMC10257313 Bergamini C, Leoni I, Rizzardi N, Melli M, Galvani G, Coada CA, et al. MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma. J Exp Clin Cancer Res. 2023;42(1):145. 10.1186/s13046-023-02718-w. 37301960 10.1186/s13046-023-02718-w PMC10257313 11. Li H Wang Y Xu Q Wang Y Wang Y Wang Y miR-373 suppresses gastric cancer metastasis by downregulating vimentin Mol Med Rep. 2018 17 3 4027 4034 10.3892/mmr.2017.8291 29257346 Li H, Wang Y, Xu Q, Wang Y, Wang Y, Wang Y, et al. miR-373 suppresses gastric cancer metastasis by downregulating vimentin. Mol Med Rep. 2018;17(3):4027–34. 10.3892/mmr.2017.8291. 29257346 10.3892/mmr.2017.8291 12. Jia W Yu T An Q Cao X Pan H MicroRNA-423-5p inhibits colon cancer growth by promoting caspase-dependent apoptosis Exp Ther Med. 2018 16 2 1225 1231 10.3892/etm.2018.6288 30116373 PMC6090304 Jia W, Yu T, An Q, Cao X, Pan H. MicroRNA-423-5p inhibits colon cancer growth by promoting caspase-dependent apoptosis. Exp Ther Med. 2018;16(2):1225–31. 10.3892/etm.2018.6288. 30116373 10.3892/etm.2018.6288 PMC6090304 13. Ferri C Di Biase A Bocchetti M Zappavigna S Wagner S Le Vu P MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer J Exp Clin Cancer Res. 2022 41 1 20 10.1186/s13046-021-02233-w 35016717 PMC8751098 Ferri C, Di Biase A, Bocchetti M, Zappavigna S, Wagner S, Le Vu P, et al. MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer. J Exp Clin Cancer Res. 2022;41(1):20. 10.1186/s13046-021-02233-w. 35016717 10.1186/s13046-021-02233-w PMC8751098 14. Arun G Diermeier SD Spector DL Therapeutic Targeting of Long Non-Coding RNAs in Cancer Trends Mol Med. 2018 24 3 257 277 10.1016/j.molmed.2018.01.001 29449148 PMC5840027 Arun G, Diermeier SD, Spector DL. Therapeutic Targeting of Long Non-Coding RNAs in Cancer. Trends Mol Med. 2018;24(3):257–77. 10.1016/j.molmed.2018.01.001. 29449148 10.1016/j.molmed.2018.01.001 PMC5840027 15. Sun Y Ma L New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis Cancers (Basel). 2019 11 2 216 10.3390/cancers11020216 30781877 PMC6406606 Sun Y, Ma L. New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis. Cancers (Basel). 2019;11(2):216. 10.3390/cancers11020216. 30781877 10.3390/cancers11020216 PMC6406606 16. Amodio N Raimondi L Juli G Stamato MA Caracciolo D Tagliaferri P MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches J Hematol Oncol. 2018 11 1 63 10.1186/s13045-018-0606-4 29739426 PMC5941496 Amodio N, Raimondi L, Juli G, Stamato MA, Caracciolo D, Tagliaferri P, et al. MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches. J Hematol Oncol. 2018;11(1):63. 10.1186/s13045-018-0606-4. 29739426 10.1186/s13045-018-0606-4 PMC5941496 17. Ren D Li H Li R Sun J Guo P Han H Novel insight into MALAT-1 in cancer: Therapeutic targets and clinical applications Oncol Lett. 2016 11 3 1621 1630 10.3892/ol.2016.4138 26998053 PMC4774567 Ren D, Li H, Li R, Sun J, Guo P, Han H, et al. Novel insight into MALAT-1 in cancer: Therapeutic targets and clinical applications. Oncol Lett. 2016;11(3):1621–30. 10.3892/ol.2016.4138. 26998053 10.3892/ol.2016.4138 PMC4774567 18. Wang T Li N Yuan L Zhao M Li G Chen Y MALAT1/miR-185-5p mediated high glucose-induced oxidative stress, mitochondrial injury and cardiomyocyte apoptosis via the RhoA/ROCK pathway J Cell Mol Med. 2023 27 17 2495 2506 10.1111/jcmm.17835 37395157 PMC10468660 Wang T, Li N, Yuan L, Zhao M, Li G, Chen Y, et al. MALAT1/miR-185-5p mediated high glucose-induced oxidative stress, mitochondrial injury and cardiomyocyte apoptosis via the RhoA/ROCK pathway. J Cell Mol Med. 2023;27(17):2495–506. 10.1111/jcmm.17835. 37395157 10.1111/jcmm.17835 PMC10468660 19. Zhao Y Zhou L Li H Sun T Wen X Li X Nuclear-Encoded lncRNA MALAT1 Epigenetically Controls Metabolic Reprogramming in Hepatocellular Carcinoma Cells through the Mitophagy Pathway Mol Ther Nucleic Acids. 2020 23 264 276 10.1016/j.omtn.2020.09.040 33425485 PMC7773746 Zhao Y, Zhou L, Li H, Sun T, Wen X, Li X, et al. Nuclear-Encoded lncRNA MALAT1 Epigenetically Controls Metabolic Reprogramming in Hepatocellular Carcinoma Cells through the Mitophagy Pathway. Mol Ther Nucleic Acids. 2020;23:264–76. 10.1016/j.omtn.2020.09.040. 33425485 10.1016/j.omtn.2020.09.040 PMC7773746 20. Stiuso P Ferranti P De Simone V Alfano L Del Vecchio L Cigliano A MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib Mol Ther Nucleic Acids. 2015 4 e233 10.1038/mtna.2015.8 25782064 Stiuso P, Ferranti P, De Simone V, Alfano L, Del Vecchio L, Cigliano A, et al. MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib. Mol Ther Nucleic Acids. 2015;4:e233. 10.1038/mtna.2015.8. 25782064 10.1038/mtna.2015.8 21. Braghini MR Lo Re O Romito I Fernandez-Barrena MG Barbaro B Pomella S Epigenetic remodelling in human hepatocellular carcinoma J Exp Clin Cancer Res. 2022 41 1 107 10.1186/s13046-022-02297-2 35331312 PMC8943959 Braghini MR, Lo Re O, Romito I, Fernandez-Barrena MG, Barbaro B, Pomella S, et al. Epigenetic remodelling in human hepatocellular carcinoma. J Exp Clin Cancer Res. 2022;41(1):107. 10.1186/s13046-022-02297-2. 35331312 10.1186/s13046-022-02297-2 PMC8943959 22. Sun B Liu C Li H Zhang L Luo G Liang S Research progress on the interactions between long non-coding RNAs and microRNAs in human cancer Oncol Lett. 2020 19 1 595 605 10.3892/ol.2019.11182 31897175 PMC6923957 Sun B, Liu C, Li H, Zhang L, Luo G, Liang S, et al. Research progress on the interactions between long non-coding RNAs and microRNAs in human cancer. Oncol Lett. 2020;19(1):595–605. 10.3892/ol.2019.11182. 31897175 10.3892/ol.2019.11182 PMC6923957 23. Zhang X Hamblin MH Yin KJ The long noncoding RNA Malat 1: Its physiological and pathophysiological functions RNA Biol. 2017 14 12 1705 1714 10.1080/15476286.2017.1358347 28837398 PMC5731810 Zhang X, Hamblin MH, Yin KJ. The long noncoding RNA Malat 1: Its physiological and pathophysiological functions. RNA Biol. 2017;14(12):1705–14. 10.1080/15476286.2017.1358347. 28837398 10.1080/15476286.2017.1358347 PMC5731810 24. Tang X Zeng X Huang Y Chen S Lin F Yang G miR-423-5p serves as a diagnostic indicator and inhibits the proliferation and invasion of ovarian cancer Exp Ther Med. 2018 15 6 4723 4730 10.3892/etm.2018.6015 29849781 PMC5960745 Tang X, Zeng X, Huang Y, Chen S, Lin F, Yang G, et al. miR-423-5p serves as a diagnostic indicator and inhibits the proliferation and invasion of ovarian cancer. Exp Ther Med. 2018;15(6):4723–30. 10.3892/etm.2018.6015. 29849781 10.3892/etm.2018.6015 PMC5960745 25. Luce A Lombardi A Ferri C Zappavigna S Tathode MS Miles AK A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells Int J Mol Sci. 2023 24 1 617 10.3390/ijms24010617 PMC9820599 36614061 Luce A, Lombardi A, Ferri C, Zappavigna S, Tathode MS, Miles AK, et al. A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells. Int J Mol Sci. 2023;24(1):617. 10.3390/ijms24010617. 10.3390/ijms24010617 PMC9820599 36614061 26. Wakizaka K Kamiyama T Kakisaka T Orimo T Nagatsu A Aiyama T Expression of Wnt5a and ROR2, Components of the Noncanonical Wnt-Signaling Pathway, is Associated with Tumor Differentiation in Hepatocellular Carcinoma Ann Surg Oncol. 2024 31 1 262 271 10.1245/s10434-023-14402-6 37814183 PMC10695870 Wakizaka K, Kamiyama T, Kakisaka T, Orimo T, Nagatsu A, Aiyama T, et al. Expression of Wnt5a and ROR2, Components of the Noncanonical Wnt-Signaling Pathway, is Associated with Tumor Differentiation in Hepatocellular Carcinoma. Ann Surg Oncol. 2024;31(1):262–71. 10.1245/s10434-023-14402-6. 37814183 10.1245/s10434-023-14402-6 PMC10695870 27. Gao T Yang X Fujisawa M Ohara T Wang T Tomonobu N SPRED2: A Novel Regulator of Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma Cells Int J Mol Sci. 2023 24 5 4996 10.3390/ijms24054996 36902429 PMC10003366 Gao T, Yang X, Fujisawa M, Ohara T, Wang T, Tomonobu N, et al. SPRED2: A Novel Regulator of Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma Cells. Int J Mol Sci. 2023;24(5):4996. 10.3390/ijms24054996. 36902429 10.3390/ijms24054996 PMC10003366 28. Mamiya T Yamazaki K Masugi Y Mori T Effendi K Du W Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis Lab Investig. 2010 90 9 1339 1345 10.1038/labinvest.2010.105 20531292 Mamiya T, Yamazaki K, Masugi Y, Mori T, Effendi K, Du W, et al. Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. Lab Investig. 2010;90(9):1339–45. 10.1038/labinvest.2010.105. 20531292 10.1038/labinvest.2010.105 29. López-Luque J, Bertran E, Crosas-Molist E, Maiques O, Malfettone A, Caja L, et al. Downregulation of Epidermal Growth Factor Receptor in hepatocellular carcinoma facilitates Transforming Growth Factor- β 10.1016/j.canlet.2019.08.011 PMC6853171 31465839 30. Wan J Liu Y Long F Tian J Zhang C circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling Cancer Sci. 2021 112 5 1707 1722 10.1111/cas.14787 33369809 PMC8088910 Wan J, Liu Y, Long F, Tian J, Zhang C. circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling. Cancer Sci. 2021;112(5):1707–22. 10.1111/cas.14787. 33369809 10.1111/cas.14787 PMC8088910 31. Wen X Du J Wang X Circ\\_0039411 promotes papillary thyroid carcinoma development through mediating the miR-423-5p/SOX4 signaling Int J Biol Markers. 2021 36 4 10 20 10.1177/17246008211043128 34738852 Wen X, Du J, Wang X. Circ_0039411 promotes papillary thyroid carcinoma development through mediating the miR-423-5p/SOX4 signaling. Int J Biol Markers. 2021;36(4):10–20. 10.1177/17246008211043128. 34738852 10.1177/17246008211043128 32. Lin Y Tsai Y Li C Wei T Wang J Lin B Overexpression of NUDT16L1 sustains proper function of mitochondria and leads to ferroptosis insensitivity in colorectal cancer Redox Biol. 2024 77 103358 10.1016/j.redox.2024.103358 39317106 PMC11465047 Lin Y, Tsai Y, Li C, Wei T, Wang J, Lin B, et al. Overexpression of NUDT16L1 sustains proper function of mitochondria and leads to ferroptosis insensitivity in colorectal cancer. Redox Biol. 2024;77:103358. 10.1016/j.redox.2024.103358. 39317106 10.1016/j.redox.2024.103358 PMC11465047 33. Kong X Patel NA Chalfant CE Cooper DR Ceramide synthesis regulates biogenesis and packaging of exosomal MALAT1 from adipose-derived stem cells, increases dermal fibroblast migration and mitochondrial function Cell Commun Signal. 2023 21 1 221 10.1186/s12964-022-00900-9 37620957 PMC10463839 Kong X, Patel NA, Chalfant CE, Cooper DR. Ceramide synthesis regulates biogenesis and packaging of exosomal MALAT1 from adipose-derived stem cells, increases dermal fibroblast migration and mitochondrial function. Cell Commun Signal. 2023;21(1):221. 10.1186/s12964-022-00900-9. 37620957 10.1186/s12964-022-00900-9 PMC10463839 ",
  "metadata": {
    "Title of this paper": "Ceramide synthesis regulates biogenesis and packaging of exosomal MALAT1 from adipose-derived stem cells, increases dermal fibroblast migration and mitochondrial function",
    "Journal it was published in:": "Journal of Experimental & Clinical Cancer Research : CR",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12487375/"
  }
}